News|Articles|December 12, 2025
Lipid-Based Formulation in Customized Enteric Capsule for Oral GLP-1 Receptor Agonist Peptide Delivery
Author(s)Lonza Capsugel
Multiple factors affect oral delivery of therapeutic peptides such as acidic and enzymatic degradation in the upper gastrointestinal tract and poor intestinal Permeability.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
From AI to Smart Factories: How Pharma Is Preparing for 2026
2
Industry Outlook 2026: Success through Top Talent, AI Utilization, and Sustainability
3
Pharma Disruption in 2025: A Recap of Our Top 10 Articles
4
HITL and HOTL: An Air Traffic Control Analogy for Agentic AI
5